Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma
(Reuters) – Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon…
Oil prices fall 1% as economic worries outweigh tanker tensions
NEW YORK (Reuters) – Oil prices fell more than 1% on Monday after more poor Chinese economic figures fanned fears of lower worldwide oil demand. FILE PHOTO: An oil rig…
GSK pharma head flags need for speed in high-pressure drug market
LONDON (Reuters) – Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain’s largest drugmaker…
Exclusive: Boeing seeking to reduce scope, duration of some physical tests for new aircraft – sources
PARIS (Reuters) – Boeing Co engineers are reducing the scope and duration of certain costly physical tests used to certify the planemaker’s new aircraft, according to industry sources and regulatory…
Canada backs startup to boost data on space debris
PARIS (Reuters) – The Canadian government’s contracting arm is backing a proposed new satellite system that will use big data analytics to provide commercially available data about the Earth and…
Boeing says will take time to win back confidence
PARIS (Reuters) – The head of Boeing said on Sunday the U.S. planemaker had made a mistake in implementing a faulty cockpit warning system on the 737 MAX and predicted…
Boeing crisis, trade tensions cast pall over air show
PARIS (Reuters) – Safety concerns, trade wars and growing security tensions in the Gulf are dampening spirits at the world’s largest planemakers as they arrive at this week’s Paris Airshow…
Nissan considers giving Renault some seats on oversight committees – source
TOKYO (Reuters) – Nissan Motor Co is considering giving its alliance partner Renault SA some seats on planned oversight committees after the French automaker expressed discontent with the envisioned governance…
Take Five: The Fed and the rest
With President Donald Trump’s trade policies heightening fears of a U.S. recession, expectations of a Fed rate cut have dramatically increased in the past month. Money market pricing became even…
Bluebird prices gene therapy at 1.58 million euros over 5 years
(Reuters) – Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five years, after winning conditional approval in Europe…